459 related articles for article (PubMed ID: 6438383)
21. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
Vinik LK; Konjicija A; Sutić N; Psorn-Rajs A; Matić M; Arslanagić N
Plucne Bolesti; 1988; 40(1-2):32-5. PubMed ID: 3141940
[No Abstract] [Full Text] [Related]
22. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
Donald PR; Diacon AH
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
[TBL] [Abstract][Full Text] [Related]
23. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
Ramarokoto H; Randriamiharisoa H; Rakotoarisaonina A; Rasolovavalona T; Rasolofo V; Chanteau S; Ralamboson M; Cauchoix B; Rakotondramarina D
Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
[TBL] [Abstract][Full Text] [Related]
24. [Isolation of atypical Mycobacteria from the patients with tuberculosis and methods of their primary identification].
Mikhaĭlova LV
Sov Zdravookhr Kirg; 1973; 4():53-5. PubMed ID: 4207845
[No Abstract] [Full Text] [Related]
25. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
Bialik IB; Klimenko MT
Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
[No Abstract] [Full Text] [Related]
26. [Efficacy of culture and biological studies of patients with destructive pulmonary tuberculosis undergoing chemotherapy].
Pashkov IuN; Lobchenko AI; Stadnikova AV
Lab Delo; 1978; (12):732-4. PubMed ID: 82669
[No Abstract] [Full Text] [Related]
27. [Smear-positive and culture-negative results in detecting acid-fast bacilli in the sputum and their clinical significance].
Gao DZ; Fan RL
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):374-6. PubMed ID: 3107941
[No Abstract] [Full Text] [Related]
28. [From the views of bacteriology--focusing on drug susceptibility test].
Ogata H
Kekkaku; 1996 Jan; 71(1):37-41. PubMed ID: 8808267
[TBL] [Abstract][Full Text] [Related]
29. [Tubercle bacilli and the defence factors for infection in sputum and bronchoalveolar lavage fluid].
Tomoda T; Takai A
Kekkaku; 1994 Dec; 69(12):743-9. PubMed ID: 7844930
[TBL] [Abstract][Full Text] [Related]
30. Smear-negative, culture-positive pulmonary tuberculosis among patients with chronic cough in Cotonou, Benin.
Affolabi D; Akpona R; Odoun M; Alidjinou K; Wachinou P; Anagonou S; Gninafon M; Trébucq A
Int J Tuberc Lung Dis; 2011 Jan; 15(1):67-70. PubMed ID: 21276299
[TBL] [Abstract][Full Text] [Related]
31. [Dynamics of the excretion of the bacilli in patients with destructive pulmonary tuberculosis under the effect of long-term tuberculostatic therapy].
Fisher EF; Velichko SA; Sharaburova OE; Strelis AK
Lab Delo; 1973; 6():340-2. PubMed ID: 4129386
[No Abstract] [Full Text] [Related]
32. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
33. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
34. [L forms of Mycobacterium tuberculosis and their clinico-epidemiological significance].
Anastasatu C; Moldovan O
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(3):203-13. PubMed ID: 3001898
[No Abstract] [Full Text] [Related]
35. [Changes in the number and virulence of tubercle bacilli isolated form pulmonary tuberculosis during short course chemotherapy].
Chen SH
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):286-8, 318. PubMed ID: 2128212
[TBL] [Abstract][Full Text] [Related]
36. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
Gomi J; Chiba Y; Yanagisawa K
Kekkaku; 1975 Feb; 50(2):55-62. PubMed ID: 815707
[No Abstract] [Full Text] [Related]
37. [Investigation of pathogens in the foci of pulmonary and osteo-articular tuberculosis].
Klimenko MT; Ginzburg TS
Probl Tuberk; 1990; (1):41-3. PubMed ID: 2110668
[TBL] [Abstract][Full Text] [Related]
38. [The rate of destruction of sensitive mycobacteria as a factor in the development of resistance in cavitating pulmonary tuberculosis].
Seri I
Prax Pneumol; 1974 May; 28(5):256-62. PubMed ID: 4210051
[No Abstract] [Full Text] [Related]
39. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Fortún J; Martín-Dávila P; Molina A; Navas E; Hermida JM; Cobo J; Gómez-Mampaso E; Moreno S
J Antimicrob Chemother; 2007 Apr; 59(4):794-8. PubMed ID: 17392354
[TBL] [Abstract][Full Text] [Related]
40. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.
Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Rüsch-Gerdes S; Mugerwa RD; Ellner JJ; Eisenach KD
Int J Tuberc Lung Dis; 2001 Jun; 5(6):579-82. PubMed ID: 11409588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
